Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,000
Closed -$465K 3212
2020
Q1
$465K Buy
+9,000
New +$432K ﹤0.01% 1988
2019
Q1
Sell
-2,300
Closed -$286K 3240
2018
Q4
$286K Buy
+2,300
New +$379K ﹤0.01% 2485

Other funds holding INGN

John Overdeck's INGN Position: Q2 2026 in Review

John Overdeck increased its Inogen (INGN) stake by 30% in Q2 2026, buying an estimated $23.1K and bringing the position to 15,015 shares worth $96.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4893.

John Overdeck first reported a position in INGN in Q4 2014 and has held it in 39 quarters since. The position peaked at $28.1M in Q2 2019. 128 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • John Overdeck held 15,015 shares of Inogen worth $96.8K as of Q2 2026.
  • John Overdeck bought 3,496 Inogen shares in Q2 2026, an estimated $23.1K.
  • Inogen made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4893 holding.
  • John Overdeck first reported a position in Inogen in Q4 2014 and has held it in 39 quarters since.
  • John Overdeck's Inogen position peaked at $28.1M in Q2 2019.
  • 128 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.